Real Time Screeners Intraday Screeners now on Real Time Data (Updated every 5 mins)
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Balance Sheet of Glaxosmithkline Pharmaceuticals (GLAXO)

Summary    Balance Sheet    Cash Flow    Income    Qtrly Income    Risk    Profitability    Qtrly Profit    Solvency    

Balance Sheet of Glaxosmithkline Pharmaceuticals Ltd.

Year 31_Mar_2019 31_Mar_2018 31_Mar_2017 31_Mar_2016 31_Mar_2015 31_Dec_2013
Book Value / Share 126.31 242.89 236.93 257.75 215.93 234.91
Common Stock 169.41 84.70 84.70 84.70 84.70 84.70
Stock Holder Fund 2139.83 2057.33 2006.86 2183.25 1828.98 1989.73
Other Stock Holder Equity 1.15 6.64 1.06 4.53 4.33 4.33
Total Permanent Equity 0 0 0 0 0 0
Reserve 1970.42 1972.63 1922.15 2098.55 1744.28 1905.03
Retained Earning 1969.27 1965.98 1921.10 2094.02 1739.95 1900.70
Non Current Liabilities 317.16 290.29 276.75 292.43 280.14 250.88
Long Term Debt 0.177 0.583 0.989 1.59 2.63 3.60
Minority Interest 0 0 0 0 0 0
Current Liabilities 1454.32 1599.86 720.23 579.21 1106.55 888.91
Accounts Payable 482.53 646.25 522.48 327.74 308.04 285.63
Defered Long term Debt 0 0 0 0 0 0
Other Current Liabilities 15.06 19.92 31.30 142.83 722.31 541.14
Other Liabilities 316.99 289.71 275.76 290.83 277.51 247.27
Total Liabilities 1771.48 1890.15 996.98 871.64 1386.69 1139.79
Property Plant Equipment 1367.10 1173.02 825.93 471.71 238.30 161.95
Goodwill 0 0 0 0 0 0
Net Tangible Assets 2074.29 1984.65 1974.61 2183.25 1828.98 1989.73
Intangible Assets 65.54 72.68 32.25 0 0 0
Inventory 486.49 500.18 425.80 525.87 375.58 346.97
Cash 98.78 1270.12 140.92 114.89 1910.61 2041.58
Other Current Assets 96.94 132.71 34.17 88.24 124.81 71.80
Current Assets 2006.13 2181.47 1672.62 2173.73 2586.98 2623.94
Non Current Assets 1905.18 1766.01 1331.22 881.16 628.68 505.59
Other Assets 469.16 515.31 471.36 409.39 390.31 343.58
Total Assets 3911.31 3947.48 3003.84 3054.88 3215.67 3129.52
Short term Investment 1049.01 1069.01 736.51 1252.06 0 10.00
Long term Investment 0.055 0.055 0.055 0.055 0.070 0.055
Short Long Term Debt 0.406 0.406 0.606 0.778 0.489 4.14
Working Capital 551.82 581.61 952.38 1594.52 1480.43 1735.03
Net Receivable 120.49 146.96 170.80 181.69 165.85 151.83


Compund Annual Growth Rate (CAGR) of Glaxosmithkline Pharmaceuticals Ltd.

Period 1 Year 3 Year 5 Year
Stock Holder Equity 4.01 % -0.667 % 1.47 %
Reserve -0.112 % -2.08 % 0.677 %
Current Liabilities -9.10 % 35.92 % 10.35 %
Total Liabilities -6.28 % 26.67 % 9.22 %
Current Assets -8.04 % -2.64 % -5.23 %
Total Assets -0.916 % 8.59 % 4.56 %
Short Term Debt 0.00 -19.49 % -37.15 %
Long Term Debt -69.64 % -51.89 % -45.26 %
Short Term Investment -1.87 % -5.73 % 153.60 %
Long Term Investment 0.00 0.00 0.00
Working Capital -5.12 % -29.79 % -20.48 %
Cash -92.22 % -4.91 % -45.43 %
Inventory -2.74 % -2.56 % 6.99 %

About Financial Data , All results are consolidated, Values are in Crores, Sourced from external Vendors


( Intraday Analysis is on Real Time Data (Updated every 5 Mins). All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)


All Rights Reserved By Mintnovate Market Research Pvt Ltd.